Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low density lipoprotein cholesterol measurement
|
1142 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.800 | 1.000 | 7 | 2007 | 2019 | ||||
Serum LDL cholesterol measurement
|
555 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.700 | 1.000 | 5 | 2008 | 2012 | ||||
Serum total cholesterol measurement
|
1243 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.800 | 1.000 | 3 | 2009 | 2019 | ||||
Triglycerides measurement
|
1418 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.800 | 1.000 | 3 | 2007 | 2019 | ||||
Coronary heart disease
|
1178 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.710 | 1.000 | 2 | 2011 | 2016 | ||||
Dyslipidemias
|
184 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.020 | 1.000 | 2 | 2013 | 2014 | ||||
Ischemic stroke
|
704 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.020 | 1.000 | 2 | 2017 | 2018 | ||||
Acute Chest Syndrome
|
135 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1 | 2018 | 2018 | |||||
Acute Coronary Syndrome
|
139 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Apraxia, Developmental Verbal
|
21 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Breast Carcinoma
|
2793 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Cardiovascular Diseases
|
711 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Cholecystolithiasis
|
62 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Cholelithiasis
|
90 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Coronary Artery Disease
|
1577 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
High density lipoprotein measurement
|
1440 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Hypercholesterolemia
|
123 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Hypercholesterolemia, Familial
|
1423 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hyperlipoproteinemia Type IIa
|
661 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Malignant neoplasm of gallbladder
|
81 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Myocardial Infarction
|
680 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Pseudocholinesterase Measurement
|
568 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||
Serum albumin measurement
|
3282 | 0.708 | 0.440 | 2 | 21009323 | synonymous variant | G/A | snv | 0.39 | 0.38 | 0.700 | 1.000 | 1 | 2012 | 2012 |